Dr. Andrew Blagborough

Biography

Andrew Blagborough is an Associate Professor in the Department of Pathology at the University of Cambridge, focusing on malaria transmission-blocking interventions. His primary research goal is to develop novel vaccines that target the sexual stages of Plasmodium parasites, essential for interrupting malaria transmission. This involves identification of new transmission-blocking targets and understanding their efficacy through extensive laboratory and field studies. He utilizes various immunization strategies including recombinant proteins and viral delivery systems to enhance both safety and efficacy of vaccines. Additionally, Blagborough's work considers the socio-ecological impacts of malaria and the potential of targeting infection in endemic communities to facilitate elimination efforts. He has collaborated with multiple international research institutions to advance his studies and has been pivotal in developing novel methodologies to evaluate vaccine candidates. His publications indicate a strong focus on how transmission-blocking antibodies can reductively decrease levels of Plasmodium in both mosquito and vertebrate hosts. Blagborough's contributions to the field are characterized by a commitment to practical solutions that address the complexities of malaria control and elimination.

Research Interests

Experience